Want to join the conversation?
Leap Therapeutics and $MCUR announced signing of definitive merger agreement whereby $MCUR will become a wholly owned subsidiary of Leap, and Leap will become a public company. Leap will apply to have the shares of the combined entity listed for trading on NASDAQ upon completion of merger. The transaction is expected to close near year-end.
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.